Literature DB >> 15863801

Relief of expressed suicidal intent by ECT: a consortium for research in ECT study.

Charles H Kellner1, Max Fink, Rebecca Knapp, Georgios Petrides, Mustafa Husain, Teresa Rummans, Martina Mueller, Hilary Bernstein, Keith Rasmussen, Kevin O'connor, Glenn Smith, A John Rush, Melanie Biggs, Shawn McClintock, Samuel Bailine, Chitra Malur.   

Abstract

OBJECTIVE: This study assessed the incidence, severity, and course of expressed suicidal intent in depressed patients who were treated with ECT. The data are from the first phase of an ongoing, collaborative multicenter study, the overall aim of which was to compare continuation ECT with pharmacotherapy in the prevention of relapse after a successful course of ECT.
METHOD: Suicidal intent, as expressed by patients during an interview, was scored at baseline and before each ECT session with item 3 on the 24-item Hamilton Depression Rating Scale in 444 patients with unipolar depression.
RESULTS: One hundred thirty-one patients (29.5%) reported suicidal thoughts and acts (score of 3 or 4) at baseline. Scores decreased to 0 after 1 week (three ECT sessions) in 38.2% of the patients, after 2 weeks (six ECT sessions) in 61.1%, and in 80.9% at the end of the course of treatment.
CONCLUSIONS: Expressed suicidal intent in depressed patients was rapidly relieved with ECT. Evidence-based treatment algorithms for major depressive mood disorders should include dichotomization according to suicide risk, as assessed by interview. For patients at risk, ECT should be considered earlier than at its conventional "last resort" position.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863801      PMCID: PMC3684568          DOI: 10.1176/appi.ajp.162.5.977

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  27 in total

1.  The quality of health care delivered to adults in the United States.

Authors:  Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

2.  Suicide and primary affective disorders.

Authors:  S B Guze; E Robins
Journal:  Br J Psychiatry       Date:  1970-10       Impact factor: 9.319

3.  ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.

Authors:  G Petrides; M Fink; M M Husain; R G Knapp; A J Rush; M Mueller; T A Rummans; K M O'Connor; K G Rasmussen; H J Bernstein; M Biggs; S H Bailine; C H Kellner
Journal:  J ECT       Date:  2001-12       Impact factor: 3.635

4.  ECT response in delusional versus non-delusional depressed inpatients.

Authors:  Tom K Birkenhäger; Esther M Pluijms; Stefan A P Lucius
Journal:  J Affect Disord       Date:  2003-04       Impact factor: 4.839

5.  Psychopathological predictors of suicide in patients with major depression during a 5-year follow-up.

Authors:  B Schneider; M Philipp; M J Müller
Journal:  Eur Psychiatry       Date:  2001-08       Impact factor: 5.361

6.  Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.

Authors:  Arif Khan; Shirin Khan; Russell Kolts; Walter A Brown
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

Review 7.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  Suicidal behaviour of psychiatric in-patients.

Authors:  H Spiessl; B Hübner-Liebermann; C Cording
Journal:  Acta Psychiatr Scand       Date:  2002-08       Impact factor: 6.392

9.  Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study.

Authors:  Maria A Oquendo; Masoud Kamali; Steven P Ellis; Michael F Grunebaum; Kevin M Malone; Beth S Brodsky; Harold A Sackeim; J John Mann
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

10.  The suicide risk of discharged psychiatric patients.

Authors:  Ting-Pong Ho
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

View more
  58 in total

Review 1.  Neuromodulation for treatment-refractory major depressive disorder.

Authors:  Nir Lipsman; Tejas Sankar; Jonathan Downar; Sidney H Kennedy; Andres M Lozano; Peter Giacobbe
Journal:  CMAJ       Date:  2013-07-29       Impact factor: 8.262

2.  Insomnia severity is an indicator of suicidal ideation during a depression clinical trial.

Authors:  W Vaughn McCall; Jill N Blocker; Ralph D'Agostino; James Kimball; Niki Boggs; Barbara Lasater; Peter B Rosenquist
Journal:  Sleep Med       Date:  2010-05-15       Impact factor: 3.492

3.  "Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?"

Authors:  Laili Soleimani; Alison Welch; James W Murrough
Journal:  Curr Treat Options Psychiatry       Date:  2015-10-16

Review 4.  Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature.

Authors:  Georgios Petrides; Kristen G Tobias; Charles H Kellner; Matthew V Rudorfer
Journal:  Neuropsychobiology       Date:  2011-07-29       Impact factor: 2.328

5.  Novel Stimulation Approaches with ECT: Why Everything Old May be New Again.

Authors:  Zafiris J Daskalakis; Yinming Sun
Journal:  Neuropsychopharmacology       Date:  2017-07       Impact factor: 7.853

Review 6.  [Anesthesia for electroconvulsive therapy].

Authors:  U Grundmann; S O Schneider
Journal:  Anaesthesist       Date:  2013-04       Impact factor: 1.041

7.  Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.

Authors:  Jennifer L Vande Voort; Elizabeth D Ballard; David A Luckenbaugh; Rebecca A Bernert; Erica M Richards; Mark J Niciu; Lawrence T Park; Rodrigo Machado-Vieira; Wallace C Duncan; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

Review 8.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

9.  Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders.

Authors:  Ausaf A Bari; Charles B Mikell; Aviva Abosch; Sharona Ben-Haim; Robert J Buchanan; Allen W Burton; Stephen Carcieri; G Rees Cosgrove; Pierre-Francois D'Haese; Zafiris Jeffrey Daskalakis; Emad N Eskandar; Jason L Gerrard; Wayne K Goodman; Benjamin David Greenberg; Robert E Gross; Clement Hamani; Zelma H T Kiss; Peter Konrad; Brian H Kopell; Lothar Krinke; Jean-Philippe Langevin; Andres M Lozano; Donald Malone; Helen S Mayberg; Jonathan P Miller; Parag G Patil; DeLea Peichel; Erika A Petersen; Ali R Rezai; R Mark Richardson; Patricio Riva-Posse; Tejas Sankar; Jason M Schwalb; Helen Blair Simpson; Konstantin Slavin; Paul H Stypulkowski; Tor Tosteson; Peter Warnke; Jon T Willie; Kareem A Zaghloul; Joseph S Neimat; Nader Pouratian; Sameer A Sheth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-25       Impact factor: 10.154

10.  The efficacy of acute electroconvulsive therapy in atypical depression.

Authors:  Mustafa M Husain; Shawn M McClintock; A John Rush; Rebecca G Knapp; Max Fink; Teresa A Rummans; Keith Rasmussen; Cynthia Claassen; Georgios Petrides; Melanie M Biggs; Martina Mueller; Shirlene Sampson; Samuel H Bailine; Sarah H Lisanby; Charles H Kellner
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.